SC 13D
SC 13D
- Company
- IMMUCELL CORP /DE/
- Filed
- August 27, 2024
- Accession Number
- 0001193125-24-207799
A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →